N.C. A&T and Industry to Bring Novel Aspirin Derivatives to the Marketplace

N.C. A&T and Industry to Bring Novel Aspirin Derivatives to the Marketplace

Dr. Shengmin Sang, a food scientist with N.C. A&T State University, licensed his patent for a family of novel aspirin-derived compounds to SARISA Therapeutics.
Source: University Reports
Permalink: N.C. A&T and Industry to Bring Novel Aspirin Derivatives to the Marketplace
#NCAT

Comments are closed.